Список литературы

Глава 11

1. Maggiore U.L.R., Ferrero S., Candiani M. et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation // Eur. Urol. 2017. Vol. 71. P. 790–807.

2. Lalani S., Choudhry A.J., Firth B. et al. Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis // Hum. Reprod. 2018. Vol. 33. № 10. P. 1854–1865.

3. Giudice L.C., Evers J.L.H., Healy D.L. Endometrisis: Science and Practice. Wiley-Blackwell, Oxford, 2012. 600 p. ISBN 978-1-4443-3213-1.

4. Matalliotakis I., Cakmak H., Dermitzaki D. et al. Increased rate of endometriosis and spontaneous abortion in an in vitro fertilization program: no correlation with epidemiological factors // Gynecol. Endocrinol. 2008. Vol. 24. № 4. P. 194–198.

5. Horton J., Sterrenburg M., Lane S. et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: A systematic review and meta-analysis // Hum. Reprod. Update. 2019. Vol. 25. P. 592–632.

6. Nirgianakis K., Gasparri M.L., Radan A.P. et al. Obstetric complications after laparoscopic excision of posterior deep infiltrating endometriosis: A case-control study // Fertil. Steril. 2018. Vol. 110. P. 459–466.

7. Juang C.M., Chou P., Yen M.S. et al. Adenomyosis and risk of preterm delivery // BJOG. 2007. Vol. 114. № 2. P. 165–169.

8. Mochimaru A., Aoki S., Oba M.S. et al. Adverse pregnancy outcomes associated with adenomyosis with uterine enlargement // J. Obstet. Gynaecol. Res. 2015. Vol. 41. № 4. P. 529–533.

9. Hashimoto A., Iriyama T., Sayama S. et al. Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition // J. Matern. Fetal. Neonatal Med. 2018. Vol. 31. № 3. P. 364–369.

10. Vercellini P., Vigano P., Somigliana E. et al. Adenomyosis: Epidemiological factors // Clin. Obstet. Gynaecol. 2006. Vol. 20. P. 465–477.

11. Abbott J.A. Adenomyosis and abnormal uterine bleeding (aub-a)-pathogenesis, diagnosis, and management // Clin. Obstet. Gynaecol. 2017. Vol. 40. P. 68–81.

12. Chapron C., Vannuccini S., Santulli P. et al. Diagnosing adenomyosis: An integrated clinical and imaging approach // Hum. Reprod. Update. 2020. Vol. 26. № 3. P. 392–411.

13. Lazzeri L., Di Giovanni A., Exacoustos C. et al. Preoperative and postoperative clinical and transvaginal ultrasound findings of adenomyosis in patients with deep infiltrating endometriosis // Reprod. Sci. 2014. Vol. 21. P. 1027–1033.

14. Tamura H., Kishi H., Kitade M. et al. Complications and outcomes of pregnant women with adenomyosis in Japan // Reprod. Med. Biol. 2017. Vol. 16. № 4. P. 330–336.

15. Yamaguchi A., Kyozuka H., Fujimori K. et al. Risk of preterm birth, low birthweight and small-for-gestational-age infants in pregnancies with adenomyosis: A cohort study of the Japan Environment and Children’s Study // Acta. Obstet. Gynecol. Scand. 2019. Vol. 98. № 3. P. 359–364.

16. Vannuccini S., Clifton V.L., Fraser I.S. et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome // Hum. Reprod. Update. 2016. Vol. 22. № 1. P. 104–115.

17. Brosens I., Derwig I., Brosens J., et al. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? // Hum. Reprod. 2010. Vol. 25. № 3. P. 569–574.

18. Brosens I., Pijnenborg R., Benagiano G. Defective myometrial spiral artery remodelling as a cause of major obstetrical syndromes in endometriosis and adenomyosis // Placenta. 2013. Vol. 34. № 2. P. 100–105.

19. Petraglia F., Arcuri F., de Ziegler D., Chapron C. Inflammation: a link between endometriosis and preterm birth // Fertil. Steril. 2012. Vol. 98. № 1. P. 36–40.

20. Jabbour H.N., Kurt J.S., Catalano R.D., Norman J.E. Inflammatory pathways in female reproductive health and disease // Reproduction. 2009. Vol. 138. P. 903–919.

21. Weiss G., Goldsmith L.T., Taylor R.N. et al. Inflammation in reproductive disorders // Reprod. Sci. 2009. Vol. 16. P. 216–229.

22. Challis J.R., Lockwood C.J., Myatt L. et al. Inflammation and pregnancy // Reprod. Sci. 2009. Vol. 16. P. 206–215.

23. Orsi N.M., Tribe R.M. Cytokine networks and the regulation of uterine function in pregnancy and parturition // J. Neuroendocrinol. 2008. Vol. 20. P. 462–469.

24. Noyes R., Hertig A., Rock J. Dating the endometrial biopsy // Fertil. Steril. 1950. Vol. 1. P. 3–25.

25. Jabbour H.N., Kelly R.W., Fraser H.M., Critchley H.O. Endocrine regulation of menstruation // Endocr. Rev. 2006. Vol. 27. P. 17–46.

26. Salamonsen L.A., Zhang J., Brasted M. Leukocyte networks and human endometrial remodeling // J. Reprod. Immunol. 2002. Vol. 57. P. 95–108.

27. McIntire R.H., Ganacias K.G., Hunt J.S. Programming of human monocytes by the uteroplacental environment // Reprod. Sci. 2008. Vol. 15. P. 437–447.

28. Petraglia F., Musacchio C., Luisi S., De Leo V. Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment // Best Pract. Res. 2007. Vol. 22. P. 235–249.

29. Jones R.L., Stoikos C., Findlay J.K., Salamonsen L.A. TGF-beta superfamily expression and actions in the endometrium and placenta // Reproduction. 2006. Vol. 132. P. 217–232.

30. Gravanis A., Makrigiannakis A., Chatzaki E. et al. Stress neuropeptides in the human endometrium: paracrine effects on cell differentiation and apoptosis // Hormones. 2002. Vol. 1. P. 139–148.

31. Florio P., Rossi M., Sigurdardottir M. et al. Paracrine regulation of endometrial function: interaction between progesterone and corticotropin-releasing factor (CRF) and activin A // Steroids. 2003. Vol. 68. P. 801–807.

32. King A.E., Critchley H.O. Oestrogen and progesterone regulation of inflammatory processes in the human endometrium // J. Steroid. Biochem. Mol. Biol. 2010. Vol. 120. P. 116–126.

33. De Ziegler D., Borghese B., Chapron C. Endometriosis and infertility: pathophysiology and management // Lancet. 2010. Vol. 376. P. 730–738.

34. Vigano P., Somigliana E., Gentilini D. et al. Back to the original question in endometriosis: implantation or metaplasia? // J. Endometriosis. 2009. Vol. 1. P. 1–8.

35. Giudice L.C. Clinical practice. Endometriosis // N. Engl J. Med. 2010. Vol. 362. P. 2389–2398.

36. Florio P., Pinzauti S., Altomare A. et al. Expression and role of peptides, proteins and growth factors in the pathogenesis of endometriosis // J. Endometriosis. 2009. Vol. 1. P. 79–93.

37. Gupta S., Agarwal A., Krajcir N., Alvarez J.G. Role of oxidative stress in endometriosis // Reprod. Biomed. Online. 2006. Vol. 13. P. 126–134.

38. Novembri R., Borges L.E, Carrarelli P. et al. Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis // J. Clin. Endocrinol. Metab. 2011. Vol. 96. P. 1145–1150.

39. Sales K., Jabbour H. Ciclooxygenase enzymes and prostaglandins in pathology of the endometrium // Reproduction. 2003. Vol. 126. P. 559–567.

40. Lousse J.C., Defrere S., Ramos R.G. et al. Involvement of iron, nuclear factor-kappa B (NF-kB) and prostaglandins in the pathogenesis of peritoneal endometriosis-associated inflammation: areview // J. Endometriosis. 2009. Vol. 1. P. 19–29.

41. Bulun S.E. Endometriosis // N. Engl. J. Med. 2009. Vol. 360. P. 268–279.

42. Ferreira M.C., Witz C.A., Hammes L.S. et al. Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum // Mol. Hum. Reprod. 2008. Vol. 14. P. 301–307.

43. Osteen K.G., Yeaman G.R., Bruner-Tran K.L. Matrixmetalloproteinases and endometriosis // Semin. Reprod. Med. 2003. Vol. 21. P. 155–164.

44. Borghese B., Chiche J.D., Vernerey D. et al. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression // Hum. Reprod. 2008. Vol. 23. P. 1207–1213.

45. Harada T., Kaponis A., Iwabe T. et al. Apoptosis in human endometrium and endometriosis // Hum. Reprod. Update. 2004. Vol. 10. P. 29–38.

46. Taylor R.N., Yu J., Torres P.B. et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis // Reprod. Sci. 2009. Vol. 16. P. 140–146.

47. Petraglia F., Calza L., Garuti G.C. et al. New aspects of placental endocrinology // J. Endocrinol. Invest. 1990. Vol. 13. P. 353–371.

48. Mesiano S., Chan E.C., Fitter J.T. et al. Progesterone with drawal and estrogen activation in human part uritionare coordinated by progesterone receptor A expression in the myometrium // J. Clin. Endocrinol. Metab. 2002. Vol. 87. P. 2924–2930.

49. Smith R. Parturition // N. Engl. J. Med. 2007. Vol. 356. P. 271–283.

50. Petraglia F., Imperatore A., Challis J.R. Neuroendocrine mechanisms in pregnancy and parturition // Endocr. Rev. 2010. Vol. 31. P. 783–816.

51. Siiteri P.K., Stites D.P. Immunologic and endocrine interrelationships in pregnancy // Biol. Reprod. 1982. Vol. 26. P. 1–14.

52. Arcuri F., Buchwalder L., Toti P. et al. Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal-maternal interface // Biol. Reprod. 2007. Vol. 76. P. 433–439.

53. Arcuri F., Toti P., Buchwalder L. et al. Mechanisms of leukocyte accumulation and activation in chorioamnionitis: interleukin 1 beta and tumor necrosis factor alpha enhance colony stimulating factor 2 expression in term decidua // Reprod. Sci. 2009. Vol. 16. P. 453–461.

54. Norwitz E.R., Schust D.J., Fisher S.J. Implantation and the survival of early pregnancy // N. Engl. J. Med. 2001. Vol. 345. P. 1400–1408.